Stay updated with breaking news from Flow Cytometry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Andreeff, MD, PhD, discusses the potential benefits of E-selectin inhibition in the AML tumor microenvironment, data that have contributed to the further development of uproleselan in this population, and additional AML targets under investigation that may broaden the treatment landscape.
/PRNewswire/ -- Providing clinical laboratory testing services and solutions to Federal, State, and Local Government entities and their partners that will...
The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.
/PRNewswire/ -- The "Industrial Microbiological QC Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type (PCR,...
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service...